Last 14,200 KRW
Change Today +1,150 / 8.81%
Volume 1.9M
054670 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 1:20 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daehan new pharm co ltd (054670)

Year over year, Daehan New Pharm Co., Ltd. has been able to grow revenues from 48.0B KRW to 56.7B KRW. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 52.10% to 41.98%. This was a driver that led to an improvement in the bottom line from a loss of 5.5B KRW to a smaller loss of 2.0B KRW.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2010
KRW
Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
4 Year
Trend
Revenues49,647.244,522.748,010.256,702.4
Other Revenues--0.0----
TOTAL REVENUES49,647.244,522.748,010.256,702.4
Cost of Goods Sold25,211.721,990.224,150.925,808.7
GROSS PROFIT24,435.622,532.523,859.430,893.7
Selling General & Admin Expenses, Total18,539.716,609.225,012.923,803.9
R&D Expenses856.637.97.318.3
Depreciation & Amortization, Total133.4305.6898.9965.1
Other Operating Expenses342.3222.1225.6270.1
OTHER OPERATING EXPENSES, TOTAL19,871.917,174.826,144.625,057.3
OPERATING INCOME4,563.75,357.7-2,285.35,836.4
Interest Expense-2,090.3-3,074.4-3,388.9-3,779.9
Interest and Investment Income197.9173.2214.5306.7
NET INTEREST EXPENSE-1,892.4-2,901.2-3,174.4-3,473.2
Currency Exchange Gains (Loss)-545.6119.1-433.0-205.2
Other Non-Operating Income (Expenses)-5,448.2-1,641.9425.3-375.0
EBT, EXCLUDING UNUSUAL ITEMS-3,322.5933.7-5,467.51,782.9
Gain (Loss) on Sale of Assets0.8-0.74.5--
EBT, INCLUDING UNUSUAL ITEMS-3,321.7932.9-5,463.01,782.9
Income Tax Expense-550.7289.465.93,737.9
Earnings from Continuing Operations-2,771.0643.6-5,528.9-1,955.0
NET INCOME-2,771.0643.6-5,528.9-1,955.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-2,771.0643.6-5,528.9-1,955.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-2,771.0643.6-5,528.9-1,955.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
054670:KS 14,200.00 KRW +1,150

054670 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 054670.
View Industry Companies
 

Industry Analysis

054670

Industry Average

Valuation 054670 Industry Range
Price/Earnings 100.0x
Price/Sales 2.9x
Price/Book 2.6x
Price/Cash Flow 163.3x
TEV/Sales 2.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEHAN NEW PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.